February 13, 2020 / 2:13 PM / 12 days ago

BRIEF-Arcutis Announces Enrollment Of First Patient In Topical Roflumilast Cream Phase 3 Open Label Extension Study In Plaque Psoriasis

Feb 13 (Reuters) - Arcutis Biotherapeutics Inc:

* ARCUTIS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN TOPICAL ROFLUMILAST CREAM PHASE 3 OPEN LABEL EXTENSION STUDY IN PLAQUE PSORIASIS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below